The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Remifentanil Hydrochloride Market Research Report 2024
Synopsis
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
The global Remifentanil Hydrochloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
This report aims to provide a comprehensive presentation of the global market for Remifentanil Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remifentanil Hydrochloride.
Report Scope
The Remifentanil Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remifentanil Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remifentanil Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remifentanil Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
The global Remifentanil Hydrochloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
This report aims to provide a comprehensive presentation of the global market for Remifentanil Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remifentanil Hydrochloride.
Report Scope
The Remifentanil Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remifentanil Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remifentanil Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remifentanil Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Remifentanil Hydrochloride Market Overview
1.1 Product Overview and Scope of Remifentanil Hydrochloride
1.2 Remifentanil Hydrochloride Segment by Type
1.2.1 Global Remifentanil Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 1mg/Pcs
1.2.3 2mg/Pcs
1.2.4 5mg/Pcs
1.3 Remifentanil Hydrochloride Segment by Application
1.3.1 Global Remifentanil Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Endotracheal Intubation Operation
1.3.3 Neurosurgery
1.3.4 Outpatient Surgery
1.3.5 Postoperative Analgesia
1.3.6 Other
1.4 Global Remifentanil Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Remifentanil Hydrochloride Revenue 2019-2030
1.4.2 Global Remifentanil Hydrochloride Sales 2019-2030
1.4.3 Global Remifentanil Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Remifentanil Hydrochloride Market Competition by Manufacturers
2.1 Global Remifentanil Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Remifentanil Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Remifentanil Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Remifentanil Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Remifentanil Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Remifentanil Hydrochloride, Product Type & Application
2.7 Remifentanil Hydrochloride Market Competitive Situation and Trends
2.7.1 Remifentanil Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Remifentanil Hydrochloride Players Market Share by Revenue
2.7.3 Global Remifentanil Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remifentanil Hydrochloride Retrospective Market Scenario by Region
3.1 Global Remifentanil Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Remifentanil Hydrochloride Global Remifentanil Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Remifentanil Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Remifentanil Hydrochloride Sales by Region: 2025-2030
3.3 Global Remifentanil Hydrochloride Global Remifentanil Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Remifentanil Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Remifentanil Hydrochloride Revenue by Region: 2025-2030
3.4 North America Remifentanil Hydrochloride Market Facts & Figures by Country
3.4.1 North America Remifentanil Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Remifentanil Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Remifentanil Hydrochloride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Remifentanil Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Remifentanil Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Remifentanil Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Remifentanil Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Remifentanil Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Remifentanil Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Remifentanil Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Remifentanil Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Remifentanil Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Remifentanil Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Remifentanil Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Remifentanil Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Remifentanil Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Remifentanil Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Remifentanil Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Remifentanil Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Remifentanil Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Remifentanil Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Remifentanil Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Remifentanil Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Remifentanil Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Remifentanil Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Remifentanil Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Remifentanil Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Remifentanil Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Remifentanil Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Remifentanil Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Remifentanil Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Remifentanil Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Remifentanil Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Remifentanil Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Remifentanil Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Remifentanil Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Remifentanil Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Remifentanil Hydrochloride Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Macfarlan Smith
6.2.1 Macfarlan Smith Corporation Information
6.2.2 Macfarlan Smith Description and Business Overview
6.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Macfarlan Smith Remifentanil Hydrochloride Product Portfolio
6.2.5 Macfarlan Smith Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Remifentanil Hydrochloride Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Remifentanil Hydrochloride Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Arevipharma
6.5.1 Arevipharma Corporation Information
6.5.2 Arevipharma Description and Business Overview
6.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Arevipharma Remifentanil Hydrochloride Product Portfolio
6.5.5 Arevipharma Recent Developments/Updates
6.6 AMRI
6.6.1 AMRI Corporation Information
6.6.2 AMRI Description and Business Overview
6.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AMRI Remifentanil Hydrochloride Product Portfolio
6.6.5 AMRI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Remifentanil Hydrochloride Industry Chain Analysis
7.2 Remifentanil Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Remifentanil Hydrochloride Production Mode & Process
7.4 Remifentanil Hydrochloride Sales and Marketing
7.4.1 Remifentanil Hydrochloride Sales Channels
7.4.2 Remifentanil Hydrochloride Distributors
7.5 Remifentanil Hydrochloride Customers
8 Remifentanil Hydrochloride Market Dynamics
8.1 Remifentanil Hydrochloride Industry Trends
8.2 Remifentanil Hydrochloride Market Drivers
8.3 Remifentanil Hydrochloride Market Challenges
8.4 Remifentanil Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
